序号 |
标题 |
次数 |
作者 |
发布时间 |
77041 |
Amino-PEG7-C6的组成与结构、化学性质 |
101 |
kx |
2024-12-13 |
77042 |
Ald-CH2-PEG2-CH2CO2 tBu ester(CAS号:2230956-95-1) |
90 |
WYQ |
2024-12-13 |
77043 |
TCO-PEG3-CH2CO2H(CAS号:2249928-25-2) |
81 |
WYQ |
2024-12-13 |
77044 |
C16-sese-mPEG , 棕榈酸双硒键甲氧基聚乙二醇 |
92 |
wyh |
2024-12-13 |
77045 |
DBCO-PEG3-CH2CO-NHS ester,CAS: 2249926-63-2 |
105 |
WYQ |
2024-12-13 |
77046 |
1425485-72-8,DBCO-C6-acid, 11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸 |
84 |
kx |
2024-12-13 |
77047 |
Acid-CH2-PEG3-CH2-t-butyl ester,CAS: 883564-93-0 |
90 |
WYQ |
2024-12-13 |
77048 |
C14-PEG-Biotin ; C14聚乙二醇生物素 |
79 |
wyh |
2024-12-13 |
77049 |
Acid-CH2-PEG5-CH2-t-butyl ester,CAS: 2244684-38-4 |
80 |
WYQ |
2024-12-13 |
77050 |
C14-494 Lipid B4, CAS:2639634-80-1 |
107 |
wyh |
2024-12-13 |
77051 |
Mal-CH2-Cyclohexylcarboxylhydrazide TFA(CAS号:181148-00-5, 359436-59-2) |
91 |
WYQ |
2024-12-13 |
77052 |
Bis-C7-NH2-Thalidomide(hydrochloride),氨基-C7-沙利度胺-C7-氨基盐酸盐 |
80 |
kx |
2024-12-13 |
77053 |
Mal-PEG3-CH2 tBu-ester(CAS号:518044-33-2) |
93 |
WYQ |
2024-12-13 |
77054 |
Mal-PEG3-CH2 NHS ester(CAS号:2230016-26-7) |
95 |
WYQ |
2024-12-13 |
77055 |
氨基-聚乙二醇-棕榈酸,NH2-PEG750-C16 palmitic acid |
95 |
wyh |
2024-12-13 |
77056 |
TCO PEG3 CH2CONHS,CAS: 2249928-26-3 |
79 |
WYQ |
2024-12-13 |
77057 |
Ald-CH2-PEG3-propargyl,CAS: 2249926-66-5 |
88 |
WYQ |
2024-12-13 |
77058 |
Thalidomide-O-C7-acid,2169266-70-8,沙利度胺-O-C7-酸 |
86 |
kx |
2024-12-13 |
77059 |
Ald-CH2-PEG4-propargyl,CAS: 1341156-62-4 |
87 |
WYQ |
2024-12-13 |
77060 |
Ald-benzoylamide-PEG4-CH2 NHS ester(CAS号:2709738-71-4) |
72 |
WYQ |
2024-12-13 |
77061 |
m-PEG10-C11-SH,甲基-十聚乙二醇-C11-巯基 |
69 |
kx |
2024-12-13 |
77062 |
L-Cysteine, S-[[3-(mercaptomethyl)-5-[[[2-[[2-[4,7,10-tris(carboxymethyl) |
100 |
h |
2024-12-13 |
77063 |
Ald-CH2-PEG2-Azide(CAS号:184006-13-1) |
88 |
WYQ |
2024-12-13 |
77064 |
CAS:78063-83-9,Tm-DOTA双功能螯合剂 |
82 |
h |
2024-12-13 |
77065 |
Ald-benzoylamide-PEG2-CH2 NHS ester(CAS号:2253965-05-6) |
76 |
WYQ |
2024-12-13 |
77066 |
m-PEG5-C11-SH,848589-24-2,甲基-五聚乙二醇-C11-巯基 |
70 |
kx |
2024-12-13 |
77067 |
NHS-PEG5000-C16,活性酯聚乙二醇棕榈酸 |
99 |
wyh |
2024-12-13 |
77068 |
CAS:2757339-62-9,DOTA-Tyr-Lys-DOTA |
88 |
h |
2024-12-13 |
77069 |
m-PEG3-C11-SH,594863-55-5,甲基-三聚乙二醇-C11-巯基 |
84 |
kx |
2024-12-13 |
77070 |
Cholesterol-PEG-CY5 CLS-PEG-CY5 |
82 |
wyh |
2024-12-13 |
77071 |
(DOTA-Lys(DOTA))2-Lys-Gly-Gly-Gly-N2H3*TFA |
82 |
h |
2024-12-13 |
77072 |
Pomalidomide-C10-COOH,2428400-33-1,泊马度胺-C10-酸 |
79 |
kx |
2024-12-13 |
77073 |
Ald-benzoylamide-PEG3-CH2 NHS ester,CAS: 2253965-10-3 |
85 |
WYQ |
2024-12-13 |
77074 |
[10-[2-[4-[3-[[4-[[[2-[(2S)-2-Cyano-4,4-difluoro-1-pyrrolidinyl] |
103 |
h |
2024-12-13 |
77075 |
Ald-CH2-PEG2-NHBoc,CAS: 1229024-41-2 |
64 |
WYQ |
2024-12-13 |
77076 |
NH2-PEG1000-C18 Stearic Acid, 氨基-聚乙二醇-硬脂酸 |
68 |
wyh |
2024-12-13 |
77077 |
Pomalidomide-C9-COOH,2243000-24-8,泊马度胺-C9-酸 |
80 |
kx |
2024-12-13 |
77078 |
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- |
80 |
h |
2024-12-13 |
77079 |
Ald-CH2-PEG3-NHBoc,CAS: 2253965-06-7 |
80 |
WYQ |
2024-12-13 |
77080 |
m-PEG11-(CH2)8-Phosphonic acid,甲基-十一聚乙二醇-C8-膦酸 |
71 |
kx |
2024-12-13 |
77081 |
DOTA-五聚乙二醇-C6-二苯并环辛炔 |
70 |
h |
2024-12-13 |
77082 |
m-PEG3-(CH2)8-Phosphonic acid,2227018-98-4,甲基-三聚乙二醇-C8-膦酸 |
118 |
kx |
2024-12-13 |
77083 |
Ald-CH2-PEG4-NHBoc(CAS号2708026-80-4) |
75 |
WYQ |
2024-12-13 |
77084 |
m-PEG7-(CH2)8-Phosphonic acid,甲基-七聚乙二醇-C8-膦酸 |
84 |
kx |
2024-12-13 |
77085 |
DOTAGA-Anhydride,DOTA衍生试剂 |
82 |
h |
2024-12-13 |